Delcath Systems, Inc.

DCTH Healthcare Medical Devices

Delcath Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 129.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.6%, EPS fell 12.5% and free cash flow fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

14.08 0.73 −4.93%
Market cap
$513.9M
P/E
1,408×
Fwd P/E
−17.8×
Dividend yield
—
F-score
7/9
Altman Z
13.26
Beneish M
−2.73
Dividend safety
n/a

Delcath Systems, Inc. (DCTH) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Delcath Systems, Inc. (DCTH) trades at a P/E ratio of 1,408×. Over the past ten years it has ranged from 0.0× (June 2025) to 1,736× (August 2026); the current reading is higher than 98% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 126× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 1,259× 171.34%
Mar 2026 464× 267.52%
Dec 2025 126× (76.51%)
Sep 2025 538× 137.13%
42 more quarters

Against its own ten years

Low 0.0× High 1,736×
Ten-year median 0.0×
Current reading's percentile 98

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on DCTH